Safety outcomes among infants exposed to Omalizumab via breastfeeding: Results from the Xolair pregnancy registry (EXPECT)

Leon, SL; Kaufman, DG; Howard, M; Mukhopadhyay, S; Fogel, R

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019; 28 (): 374